Fulton Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History

Fulton Bank’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$231K	Buy	+2,426	New	+$259K	0.01%	631

Other funds holding RYTM

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.08B AUM 12.02% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

EWP

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Fulton Bank's RYTM Position: Q3 2026 in Review

Fulton Bank opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2026: 2,426 shares worth $231K. The stake represents 0.01% of the portfolio and ranks #631 among its holdings.

21 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

Fulton Bank held 2,426 shares of Rhythm Pharmaceuticals worth $231K as of Q3 2026.
Rhythm Pharmaceuticals was a new Fulton Bank position in Q3 2026.
Rhythm Pharmaceuticals made up 0.01% of Fulton Bank's portfolio in Q3 2026, its #631 holding.
21 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Fulton Bank's 13F filing for Q3 2026, filed 14 Oct 2026.